For patients with alcohol-related liver disease who require transplantation, there is mixed evidence supporting the requirement that patients abstain from alcohol consumption for 6 months prior to transplantation.
The investigators sought to determine the down-staging success rate and intention-to-treat outcomes according to uniform criteria in patients with hepatocellular carcinoma.
Researchers investigated the impact of COVID-19 on patients waiting for liver transplants, as well as on the clinical course following transplantation.
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Investigators assessed the benefit of a potential living donor on survival in patients with hepatocellular carcinoma on a waiting list for a liver transplant.
Researchers evaluated the rates of and factors associated with referral, wait-listing, and receipt of liver allografts.
Investigators assessed whether a recently implemented policy was associated with changes in travel distance for organ recovery and number of organ imports and exports.
A study was conducted to assess racial, gender, and socioeconomic disparities related to liver transplantation, including referral, waitlisting practices, allocation, and post-transplant care.
A team of researchers sought to determine whether neighborhood deprivation affected outcomes in pediatric patients having undergone hepatic transplantation.
Women are more likely than men to die waiting for a liver transplant.
Simultaneous splenectomy may prevent small-for-size graft syndrome in adults with a living donor liver transplantation.
Female candidates for liver transplant who have portopulmonary hypertension have higher pulmonary vascular resistance, lower Model for End-Stage Liver Disease scores, and are more likely to have autoimmune liver disease, compared with male candidates.
For adults with noninfectious uveitis, mycophenolate mofetil is not associated with superior control of inflammation compared with methotrexate.